A detailed history of Nissay Asset Management Corp transactions in Catalent, Inc. stock. As of the latest transaction made, Nissay Asset Management Corp holds 21,847 shares of CTLT stock, worth $1.29 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,847
Previous 21,447 1.87%
Holding current value
$1.29 Million
Previous $1.21 Million 9.79%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $22,464 - $24,384
400 Added 1.87%
21,847 $1.32 Million
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $20,199 - $21,496
377 Added 1.79%
21,447 $1.21 Million
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $8,809 - $12,382
207 Added 0.99%
21,070 $1.19 Million
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $29,509 - $42,704
-917 Reduced 4.21%
20,863 $937,000
Q3 2023

Nov 14, 2023

BUY
$44.2 - $50.2 $29,216 - $33,182
661 Added 3.13%
21,780 $991,000
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $17,873 - $37,732
561 Added 2.73%
21,119 $915,000
Q1 2023

May 15, 2023

SELL
$45.44 - $74.26 $27,536 - $45,001
-606 Reduced 2.86%
20,558 $1.35 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $10,430 - $20,412
252 Added 1.21%
21,164 $952,000
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $53,039 - $82,902
733 Added 3.63%
20,912 $1.51 Million
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $3,575 - $4,676
-41 Reduced 0.2%
20,179 $2.17 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $49,167 - $64,983
522 Added 2.65%
20,220 $2.24 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $46,393 - $53,959
388 Added 2.01%
19,698 $2.52 Million
Q3 2021

Nov 10, 2021

BUY
$109.17 - $142.35 $304,802 - $397,441
2,792 Added 16.9%
19,310 $2.57 Million
Q2 2021

Aug 13, 2021

SELL
$100.34 - $115.69 $15,352 - $17,700
-153 Reduced 0.92%
16,518 $1.79 Million
Q1 2021

May 11, 2021

SELL
$101.51 - $125.27 $40,807 - $50,358
-402 Reduced 2.35%
16,671 $1.76 Million
Q4 2020

Feb 08, 2021

BUY
$85.88 - $105.36 $63,722 - $78,177
742 Added 4.54%
17,073 $1.78 Million
Q3 2020

Oct 20, 2020

BUY
$72.74 - $92.5 $17,821 - $22,662
245 Added 1.52%
16,331 $1.4 Million
Q2 2020

Jul 27, 2020

BUY
$48.02 - $79.04 $772,449 - $1.27 Million
16,086 New
16,086 $1.18 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.